| Common genetic variation drives molecular heterogeneity in human iPSCs H Kilpinen, A Goncalves, A Leha, V Afzal, K Alasoo, S Ashford, S Bala, ... Nature 546 (7658), 370-375, 2017 | 573 | 2017 |
| CA19-9 for detecting recurrence of pancreatic cancer A Azizian, F Rühlmann, T Krause, M Bernhardt, P Jo, A König, M Kleiß, ... Scientific Reports 10 (1), 1-10, 2020 | 145 | 2020 |
| Explaining decisions of graph convolutional neural networks: patient-specific molecular subnetworks responsible for metastasis prediction in breast cancer H Chereda, A Bleckmann, K Menck, J Perera-Bel, P Stegmaier, F Auer, ... Genome medicine 13, 1-16, 2021 | 77 | 2021 |
| Proteomic analysis of tear fluid reveals disease-specific patterns in patients with Parkinson's disease–A pilot study M Boerger, S Funke, A Leha, AE Roser, AK Wuestemann, F Maass, ... Parkinsonism & related disorders 63, 3-9, 2019 | 69 | 2019 |
| A machine learning approach for the prediction of pulmonary hypertension A Leha, K Hellenkamp, B Unsöld, S Mushemi-Blake, AM Shah, ... PloS one 14 (10), e0224453, 2019 | 61 | 2019 |
| ROCK-ALS: protocol for a randomized, placebo-controlled, double-blind phase IIa trial of safety, tolerability and efficacy of the rho kinase (ROCK) inhibitor fasudil in … P Lingor, M Weber, W Camu, T Friede, R Hilgers, A Leha, C Neuwirth, ... Frontiers in neurology 10, 293, 2019 | 60 | 2019 |
| Epidermal growth factor signaling promotes sleep through a combined series and parallel neural circuit J Konietzka, M Fritz, S Spiri, R McWhirter, A Leha, S Palumbos, WS Costa, ... Current biology 30 (1), 1-16. e13, 2020 | 49 | 2020 |
| Utilizing Molecular Network Information via Graph Convolutional Neural Networks to Predict Metastatic Event in Breast Cancer. H Chereda, A Bleckmann, F Kramer, A Leha, T Beissbarth GMDS, 181-186, 2019 | 47 | 2019 |
| A high-content platform to characterise human induced pluripotent stem cell lines A Leha, N Moens, R Meleckyte, OJ Culley, MK Gervasio, M Kerz, ... Methods 96, 85-96, 2016 | 47 | 2016 |
| Elemental fingerprint as a cerebrospinal fluid biomarker for the diagnosis of Parkinson's disease F Maass, B Michalke, A Leha, M Boerger, I Zerr, JC Koch, L Tönges, ... Journal of neurochemistry 145 (4), 342-351, 2018 | 46 | 2018 |
| Applications of artificial intelligence/machine learning approaches in cardiovascular medicine: A systematic review with recommendations S Friedrich, S Groß, IR König, S Engelhardt, M Bahls, J Heinz, C Huber, ... European Heart Journal-Digital Health 2 (3), 424-436, 2021 | 45 | 2021 |
| Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients M Mannil, A Solari, A Leha, AL Pelayo-Negro, J Berciano, ... Neuromuscular Disorders 24 (11), 1003-1017, 2014 | 41 | 2014 |
| Comprehensive identification of genes driven by ERV9-LTRs reveals TNFRSF10B as a re-activatable mediator of testicular cancer cell death U Beyer, SK Krönung, A Leha, L Walter, M Dobbelstein Cell Death & Differentiation 23 (1), 64-75, 2016 | 38 | 2016 |
| Identifying extrinsic versus intrinsic drivers of variation in cell behavior in human iPSC lines from healthy donors A Vigilante, A Laddach, N Moens, R Meleckyte, A Leha, A Ghahramani, ... Cell reports 26 (8), 2078-2087. e3, 2019 | 36 | 2019 |
| Gender affects acute organ toxicity during radiochemotherapy for rectal cancer: long-term results of the German CAO/ARO/AIO-94 phase III trial HA Wolff, LC Conradi, T Beissbarth, A Leha, W Hohenberger, S Merkel, ... Radiotherapy and Oncology 108 (1), 48-54, 2013 | 36 | 2013 |
| The detection of isochromosome i (12p) in malignant germ cell tumours and tumours with somatic malignant transformation by the use of quantitative real‐time polymerase chain … A Fichtner, A Richter, S Filmar, NT Gaisa, S Schweyer, H Reis, ... Histopathology 78 (4), 593-606, 2021 | 35 | 2021 |
| Increased alpha-synuclein tear fluid levels in patients with Parkinson’s disease F Maass, S Rikker, V Dambeck, C Warth, L Tatenhorst, I Csoti, M Schmitz, ... Scientific reports 10 (1), 8507, 2020 | 35 | 2020 |
| Clinical evaluation of chairside‐fabricated partial crowns composed of zirconia‐reinforced lithium silicate ceramics: 3‐year results of a prospective practice‐based study S Rinke, T Pfitzenreuter, A Leha, M Roediger, D Ziebolz Journal of Esthetic and Restorative Dentistry 32 (2), 226-235, 2020 | 35 | 2020 |
| Biomarkers predict outcome in Charcot-Marie-Tooth disease 1A R Fledrich, M Mannil, A Leha, C Ehbrecht, A Solari, AL Pelayo-Negro, ... Journal of Neurology, Neurosurgery & Psychiatry 88 (11), 941-952, 2017 | 34 | 2017 |
| Elemental fingerprint: Reassessment of a cerebrospinal fluid biomarker for Parkinson's disease F Maass, B Michalke, D Willkommen, A Leha, C Schulte, L Tönges, ... Neurobiology of disease 134, 104677, 2020 | 33 | 2020 |
